Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pelican Therapeutics

Request full access

Next generation T Cell Immunotherapy for Cancer

Boca Raton, United StatesFounded 2009Biotech & Life Sciences

About Pelican Therapeutics

Pelican Therapeutics, a subsidiary of Heat Biologics, is a pioneering biotech company focused on developing first-in-class therapeutics aimed at achieving in vivo regulatory T cell expansion in humans. The company operates in the biopharmaceutical market, targeting both clinical and research sectors. Pelican Therapeutics primarily serves healthcare providers, research institutions, and pharmaceutical companies looking for advanced immunotherapy solutions. The business model revolves around the development and commercialization of novel T cell costimulators, such as their flagship product PTX-35, which selectively stimulates memory CD8 T cells. Revenue is generated through grants, partnerships, and eventual product sales upon regulatory approval. The company has secured significant funding, including a $15.2 million CPRIT grant, to advance its research and development efforts.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
3
Open positions
None listed
Dealroom signal
26.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Mar 2017 $0 — Scorpius Holdings ↗
EARLY VC✓Equity / VC May 2016 $15M $61M Cancer Prevention and Research Institute of Texas (CPRIT) —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Pelican Therapeutics website traffic

Latest recorded traffic for Pelican Therapeutics is 60 monthly website visits, down 73.9% over the last three months. Pelican Therapeutics's team grew 0% over the past year.

Latest monthly visits60 3-month web change-73.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Pelican Therapeutics in the Boca Raton ecosystem

Live from Dealroom

The Pelican Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Cancer Prevention and Research Institute of Texas (CPRIT)

Other known investors3 additional known investors

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boca Raton HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pelican Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pelican Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.